By

Sara Dagen

DHS Announces Cooling Solutions Prize Challenge Finalists in Celebration of Earth Day

UF startup Micro Nano Technologies, announced as finalists in the Cooling Solutions Challenge prize competition. Launched in September 2021, by DHS Science and Technology Directorate (S&T) and the Federal Emergency Management Agency (FEMA), this $195,000 prize competition marks the first in a series focusing on national climate resilience.

Pushy Plants? Student Discovery ‘Adds New Dimension to Plant Biology’

A new University of Florida study conducted by mathematics and botany senior Camille Sicangco, has been accepted for publication in Current Biology and shows the plant exerts force on its own, not just in response to external forces such as climate and soil. It is rare for an undergraduate student to publish research in such a prestigious journal — let alone to do so using new methods of discovery — but advisor Dr. Francis E. “Jack” Putz encouraged the naturally creative and inquisitive Sicangco to follow her curiosity.

The Livestock–Childhood Gut Health Link

Environmental enteric dysfunction, also called EED, is characterized by a chronic inflammation of the gut. It is a silent health problem in middle to low-income countries—and pathogens affecting the intestines are thought to play a role in its development. That said, UF students and researchers address the links between intestinal pathogens, livestock, and children’s gut health.

Does Medical Marijuana Work? Florida Consortium Seeks Answers

A consortium of nine universities in Florida, led by two professors at UF, is in the early stages of investigating medical marijuana. In this episode, Professor Almut Winterstein describes the consortium, its three major efforts and the opportunities and challenges in understanding how marijuana works as a medical treatment.

Oragenics To Participate at the World Vaccine Congress Washington 2022

Oragenics, Inc. (“Oragenics” or the “Company”), a biotech company dedicated to fighting infectious diseases including coronavirus, announced that Kimberly Murphy, a member of the Company’s Board of Directors, will attend the upcoming World Vaccine Congress Washington that will be held on April 18-22 to showcase the Company’s lead product, NT-CoV2-1, an intranasal vaccine candidate, and to pursue business development opportunities.